Skip to content

Two-level concept for pediatric practices and parents for the rational use of antibiotics, antipyretics, and emergency consultations

Two-level concept for pediatric practices and parents for the rational use of antibiotics, antipyretics, and emergency consultations - Fit for fever

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00038020
Enrollment
344
Registered
2025-09-30
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A00-B99 J00-J06 J09-J18 J20-J22 H65 R50 L00-L08 N30

Interventions

Group 1: New form of care: Standardized 3-5 minute medical consultation on how to deal with fever and further information for all children under 6 years of age. Pediatricians and adolescent medicine

Sponsors

Private Universität Witten/Herdecke
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 5 Years

Inclusion criteria

Inclusion criteria: - The practice is approved by the Association of Statutory Health Insurance Physicians. - It is a pediatric practice (specialist group 34). - The practice uses the BVKJ Service Center practice app. - The practice agrees to participate in the study. Inclusion criteria for parents in the education program: - Treatment in one of the participating pediatric practices - Children are insured by a statutory health insurance fund - Legal guardians are at least 18 years of age - Legal guardians are able to understand the study documents (cognitively and linguistically) - Children under 6 years of age who have not undergone U9

Exclusion criteria

Exclusion criteria: - Practices specializing in pediatric surgery or other highly specialized areas without U examinations

Design outcomes

Primary

MeasureTime frame
Systemic antibiotic prescription rate as the number of all prescriptions per facility in 2027 divided by the number of children, born between 2021 and 2027 (age below < 6 years), who were treated in that year.

Secondary

MeasureTime frame
a.) Antipyretic prescription rate as the number of all prescriptions per facility in 2027 divided by the number of children, born between 2021 and 2027 (age below < 6 years), who were treated in that year Outcomes for a subgroup: b.) Proportion of children with at least one antibiotic prescription per facility in 2027 (based on the number of children born between 2021 and 2027 treated in that year) c.) Proportion of children with at least one antipyretic prescription per facility in 2027 (based on the number of children born between 2021 and 2027 treated in that year) d.) Antibiotic prescription rate as the number of all prescriptions per facility in 2027 in the presence of a defined diagnosis divided by the number of children born between 2021 and 2027 with a defined diagnosis (ICD-10 diagnoses (code G for verified): A00-B99 (certain infectious and parasitic diseases), J00-J06 (upper respiratory tract infections), J09-J18 (influenza and influenza-like illnesses), J19-J22 (chronic respiratory diseases), J23-J27 (chronic respiratory diseases, other), J28-J31 (chronic respiratory diseases, unspecified), J32-J35 (chronic respiratory diseases, unspecified, other), J3 A00-B99 (certain infectious and parasitic diseases), J00- J06 (upper respiratory tract infections), J09-J18 (influenza and pneumonia), J20-J22 (lower respiratory tract), H65-H67 (otitis media), R50 (fever), L00-L08 (skin infections) or N39, N30 (urinary tract infection). e.) Antipyretic prescription rate as the number of all prescriptions per facility in 2027 in the presence of a defined diagnosis divided by the number of children born between 2021 and 2027 with a defined diagnosis (ICD-10 diagnoses (code G for verified): A00-B99 (certain infectious and parasitic diseases), J00-J06 (upper respiratory tract infections), J09-J18 (influenza and influenza-like illnesses), J19-J22 (chronic respiratory diseases), J23-J27 (chronic respiratory diseases, other), J28-J31 (chronic respiratory diseases, uns

Countries

Germany

Contacts

Public ContactEkkehart Jenetzky

Private Universität Witten/Herdecke

ekkehart.jenetzky@uni-wh.de+492302 926 7730

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026